EP3515450A4 - METHOD AND COMPOSITIONS FOR STIMULATING AND REINFORCING TISSUE REGENERATION - Google Patents

METHOD AND COMPOSITIONS FOR STIMULATING AND REINFORCING TISSUE REGENERATION Download PDF

Info

Publication number
EP3515450A4
EP3515450A4 EP17853814.6A EP17853814A EP3515450A4 EP 3515450 A4 EP3515450 A4 EP 3515450A4 EP 17853814 A EP17853814 A EP 17853814A EP 3515450 A4 EP3515450 A4 EP 3515450A4
Authority
EP
European Patent Office
Prior art keywords
stimulation
regeneration
enhancement
tissues
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP17853814.6A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP3515450A1 (en
Inventor
Michael Alan Zasloff
Viravuth Pho Yin
Kevin B. Strange
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mount Desert Island Biological Laboratory
Original Assignee
Mount Desert Island Biological Laboratory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/272,098 external-priority patent/US20170007624A1/en
Application filed by Mount Desert Island Biological Laboratory filed Critical Mount Desert Island Biological Laboratory
Publication of EP3515450A1 publication Critical patent/EP3515450A1/en
Publication of EP3515450A4 publication Critical patent/EP3515450A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP17853814.6A 2016-09-21 2017-09-20 METHOD AND COMPOSITIONS FOR STIMULATING AND REINFORCING TISSUE REGENERATION Withdrawn EP3515450A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/272,098 US20170007624A1 (en) 2012-12-20 2016-09-21 Methods and compositions for stimulation and enhancement of regeneration of tissues
PCT/US2017/052516 WO2018057624A1 (en) 2016-09-21 2017-09-20 Methods and compositions for stimulation and enhancement of regeneration of tissues

Publications (2)

Publication Number Publication Date
EP3515450A1 EP3515450A1 (en) 2019-07-31
EP3515450A4 true EP3515450A4 (en) 2020-07-29

Family

ID=61689739

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17853814.6A Withdrawn EP3515450A4 (en) 2016-09-21 2017-09-20 METHOD AND COMPOSITIONS FOR STIMULATING AND REINFORCING TISSUE REGENERATION

Country Status (4)

Country Link
EP (1) EP3515450A4 (ja)
JP (1) JP2019529558A (ja)
CA (1) CA3037712A1 (ja)
WO (1) WO2018057624A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101799214B1 (ko) * 2016-12-01 2017-11-20 재단법인 전남생물산업진흥원 모새나무 열매 추출물을 포함하는 우울증 예방 및 개선용 건강기능성 식품조성물
WO2022007894A1 (zh) * 2020-07-08 2022-01-13 北京荣祥再生医学研究所有限公司 一种调节musashi1在细胞中表达水平的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000009137A2 (en) * 1998-08-12 2000-02-24 Magainin Pharmaceuticals, Inc. Aminosterol compounds and uses thereof
US20010046521A1 (en) * 1996-04-26 2001-11-29 Michael Zasloff Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1827766B (zh) * 2001-06-28 2010-08-25 徐荣祥 体外细胞的培养方法
CA2570407C (en) * 2003-06-25 2014-01-07 Ottawa Health Research Institute Methods and compositions for modulating stem cell growth and differentiation
KR101511184B1 (ko) * 2006-11-01 2015-04-15 러트거즈,더스테이트유니버시티오브뉴저지 제대혈 줄기 세포 증식 및 성장 인자 생산에 관한 리튬 자극
WO2010011185A1 (en) * 2008-07-21 2010-01-28 Agency For Science, Technology And Research Stem cells obtained through in vitro culture with heparan sulfate
US20170007624A1 (en) * 2012-12-20 2017-01-12 Mount Desert Island Biological Laboratory Methods and compositions for stimulation and enhancement of regeneration of tissues
JP6434916B2 (ja) * 2012-12-20 2018-12-05 マウント デザート アイランド バイオロジカル ラボラトリー 組織の再生の刺激および促進

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010046521A1 (en) * 1996-04-26 2001-11-29 Michael Zasloff Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities
WO2000009137A2 (en) * 1998-08-12 2000-02-24 Magainin Pharmaceuticals, Inc. Aminosterol compounds and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
NORBERT VIDA ET AL: "Polyamine conjugates of stigmasterol", STEROIDS, vol. 77, no. 12, 28 July 2012 (2012-07-28), pages 1212 - 1218, XP055060720, ISSN: 0039-128X, DOI: 10.1016/j.steroids.2012.07.009 *
See also references of WO2018057624A1 *

Also Published As

Publication number Publication date
WO2018057624A4 (en) 2018-05-17
WO2018057624A1 (en) 2018-03-29
JP2019529558A (ja) 2019-10-17
EP3515450A1 (en) 2019-07-31
CA3037712A1 (en) 2018-03-29

Similar Documents

Publication Publication Date Title
EP3675882A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
EP3448398A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISORDERS
EP3534907A4 (en) COMPOSITIONS AND METHODS FOR TREATING HEPATIC DISEASE
EP3490581A4 (en) NEUROMODULATING COMPOSITIONS AND RELATED THERAPEUTIC PROCEDURES FOR TREATMENT OF CANCER
EP3389672A4 (en) COMPOSITIONS AND METHODS FOR TREATING HEPATIC DISEASES
EP3390634A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF EYE DISEASES
EP3368559A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANCER
EP3347469A4 (en) METHOD AND COMPOSITIONS FOR TREATING GLAUCOMA
EP3668993A4 (en) HEPATIC DISEASE TREATMENT METHODS
EP3233051A4 (en) Compositions and methods for improving the appearance of the skin
EP3390666A4 (en) COMPOSITIONS AND METHODS FOR TREATING RENAL DISEASES
EP3341391A4 (en) COMPOSITIONS AND METHODS OF PAIN TREATMENT
EP3408344A4 (en) METHOD AND COMPOSITIONS FOR BORING TREATMENT
EP3585817A4 (en) COMPOSITIONS AND METHODS OF TREATMENT OF CANCER
EP3538119A4 (en) COMPOSITIONS AND METHODS FOR TREATING SKIN DISEASES AND MAINTAINING HEALTHY SKIN
EP3151786A4 (en) Compositions and methods for regeneration of hard tissues
EP3713583A4 (en) METHODS AND COMPOSITIONS FOR TREATMENT OF THE SKIN
EP3353204A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
EP3405172A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF SKIN AGING
EP3131556A4 (en) Methods and compositions for treatment of copd diseases
EP3429584A4 (en) COMPOSITIONS AND METHODS FOR TREATING PRESBYOPIA
EP3240577A4 (en) Methods and compositions for treating brain diseases
EP3484526A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEART DISEASE
EP3481958A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF RDH12-RELATED DISORDERS AND DISEASES
EP3713553A4 (en) COMPOSITIONS AND METHODS OF TREATMENT OF EYE DISEASES

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190320

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 45/06 20060101ALI20200319BHEP

Ipc: A61P 21/00 20060101ALI20200319BHEP

Ipc: A61P 43/00 20060101ALI20200319BHEP

Ipc: A61K 31/575 20060101AFI20200319BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20200625

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 21/00 20060101ALI20200619BHEP

Ipc: A61K 45/06 20060101ALI20200619BHEP

Ipc: A61P 43/00 20060101ALI20200619BHEP

Ipc: A61K 31/575 20060101AFI20200619BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20210126